News
Is it possible that a simple sound can hurt you? That the sound of a bird singing in the yard can make you scream out in pain ...
Fast Track Designation (FTD) granted for the treatment of patients with metastatic PDAC with high IL1RAP expression levels.Reflects high unmet medical need in metastatic PDAC.Facilitates further ...
GOTHENBURG, SWEDEN / ACCESS Newswire / June 11, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Today, on Wednesday June 11, 2025, IRLAB Therapeutics AB held its Annual General Meeting.The ...
KITCHENER, ON / ACCESS Newswire / June 11, 2025 / Cloud DX Inc. ("Cloud DX") (TSXV:CDX)(OTCQB:CDXFF) reports that it has received a Cease Trade Order from the Ontario Securities Commission (OSC) on ...
Key Takeaways from NEXT Pharma 2025At NEXT Pharma 2025, one message resonated across every panel, and breakout session: AI is ...
The landscape of clinical trials is rapidly transforming. As we move through 2025, smarter technologies and patient-centric ...
Notable Systems continues to expand its executive team with two key appointments: Brian Nannie, former Chief Data Officer at Lincare, joins as Senior Vice President of Client Strategy & Innovation, ...
Thrive Medical Billing, a premier medical billing and coding company, is setting new standards in the healthcare industry by ...
To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of crofelemer from CID to treatment of general, non-infectious diarrhea in ...
MISSOULA, MONTANA / ACCESS Newswire / June 11, 2025 / Venture Medical, LLC, a leader in wound care solutions, today announced its acquisition of certain assets of ProgenaCare Global, LLC, a ...
FRANKLIN, NJ / ACCESS Newswire / June 11, 2025 / Silver Scott Health, Inc., a division of Silver Scott Mines, Inc. (OTC Pink:SILS), today announced the upcoming launch of its "Talk to a Nurse" feature ...
OKYO Pharma to Present at the Bio International ConventionLONDON and NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results